News related to Prolia (Denosumab) and/or conditions it is approved for
Osteoporosis drug found safe in long-term trial
Source: Bones / Orthopedics News From Medical News Today [2017.03.21]
A new study provides reassuring information about the short-term and long-term safety of denosumab, a monoclonal antibody that is used to treat postmenopausal osteoporosis.
Potential early warning signs of osteoporosis found in South Asian women
Source: Bones / Orthopedics News From Medical News Today [2017.03.23]
Pre-menopausal South Asian women could be more at risk of developing osteoporosis in later life than white Caucasian women, a new study in the Journal Bone reports.
Osteoporosis Fractures May Be Deadlier for Men
Source: MedicineNet Mens Health Specialty [2017.03.15]
Title: Osteoporosis Fractures May Be Deadlier for Men
Category: Health News
Created: 3/15/2017 12:00:00 AM
Last Editorial Review: 3/15/2017 12:00:00 AM
Source: MedicineNet Cerebral Palsy Specialty [2017.02.02]
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 2/2/2017 12:00:00 AM
What Is Osteoporosis? Treatment, Symptoms, Medication
Source: MedicineNet calcium carbonate Specialty [2016.07.28]
Title: What Is Osteoporosis? Treatment, Symptoms, Medication
Created: 4/23/2009 12:00:00 AM
Last Editorial Review: 7/28/2016 12:00:00 AM
Osteoporosis Super-Foods for Strong Bones With Pictures
Source: MedicineNet etidronate Specialty [2016.06.10]
Title: Osteoporosis Super-Foods for Strong Bones With Pictures
Created: 2/3/2009 12:00:00 AM
Last Editorial Review: 6/10/2016 12:00:00 AM
Population health: Statewide study finds decreasing rates of osteoporosis treatment
Source: Compliance News From Medical News Today [2015.09.15]
A statewide study has found that from 2005 to 2012, fewer than a quarter of men and women with documentation of osteoporosis or fragility fracture, conditions for which national guidelines would...
U.S. Appeals Court Revives Fosamax Warning Claims Against Merck
Source: Medscape Orthopaedics Headlines [2017.03.23]
A federal appeals court on Wednesday revived hundreds of claims by plaintiffs who accused Merck & Co of failing to adequately warn about the risks of thigh bone fractures associated with its osteoporosis drug Fosamax (alendronate).
Reuters Health Information
Suppressing protein alleviates radiation-induced bone loss in animal model
Source: Radiology / Nuclear Medicine News From Medical News Today [2016.11.09]
Penn study shows how to protect bone-forming cells, with implications for reducing osteoporosis caused by cancer therapy.